Log In
Print
BCIQ
Print
Print this Print this
 

NNZ-2591

  Manage Alerts
Collapse Summary General Information
Company Neuren Pharmaceuticals Ltd.
DescriptionOral diketopiperazine compound, a cyclic dipeptide
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today